Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 11, 1999

View Archived Issues

Genset Adds To R&D Focus, Delays Time To Profitability

Genome Of Malaria Parasite Reveals Many Drug Targets

EPO To Grant Patents On GMOs, Cells and Genes

Ethics Committee Seeks Protections For Patients

OECD Starts To Look At Biotech Issues In EU

Investors Push CSL Higher After Deal With Red Cross

Creating Value Theme Of France Biotech Congress

UK Offers Grants To Move Biotech Forward

Elan Stops Development Of Antegren For Acute MS

New Venture Fund Created To Finance 10 New Companies

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.